Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001104659-18-074499
Filing Date
2018-12-21
Accepted
2018-12-21 17:06:18
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13D/A a18-41983_1sc13da.htm SC 13D/A 41129
  Complete submission text file 0001104659-18-074499.txt   42417
Mailing Address C/O ALNYLAM PHARMACEUTICALS, INC 300 THIRD STREET CAMBRIDGE MA 02142
Business Address
Westphal Christoph H (Filed by) CIK: 0001291961 (see all company filings)

Type: SC 13D/A

Mailing Address 800 BOYLSTON STREET 24TH FLOOR BOSTON MA 02199
Business Address 800 BOYLSTON STREET 24TH FLOOR BOSTON MA 02199 617-874-1821
Flex Pharma, Inc. (Subject) CIK: 0001615219 (see all company filings)

EIN.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-88731 | Film No.: 181250399
SIC: 2834 Pharmaceutical Preparations